key: cord-0921543-1ifudhx0
authors: Lv, Zhihua; Wang, Wei; Qiao, Bin; Cui, Xianghua; Feng, Yong; Chen, Lang; Ma, Qingfeng; Liu, Xinghui
title: The prognostic value of general laboratory testing in patients with COVID‐19
date: 2020-12-13
journal: J Clin Lab Anal
DOI: 10.1002/jcla.23668
sha: 64afe6994c6edb962622b5201443ba46025abf49
doc_id: 921543
cord_uid: 1ifudhx0

BACKGROUND: Lymphocyte count (LYM) of peripheral blood and some indices of general biochemical analysis had diagnostic and prognostic value for coronavirus disease 2019 (COVID‐19), and the value of other remaining indices is rare. METHODS: A total of 94 patients with COVID‐19 were enrolled at Renmin Hospital of Wuhan University. According to the severity of COVID‐19, the patients were divided into three groups (moderate 49, severe 35, and critical 10), and 40 healthy cases were enrolled in the same period as healthy controls. The diagnostic and prognostic value of indices in peripheral blood cell count and general biochemical analysis was analyzed. RESULTS: Compared with healthy cases, the value differences in peripheral blood analysis in patients with COVID‐19 were statistically significant (p < 0.01), the differences in LYM, neutrophil count (Neu), platelet count (PLT), and white blood cell count (WBC) were statistically significant among different severity of COVID‐19 (p < 0.05). Compared with healthy cases, the differences in general biochemical results in patients with COVID‐19 were statistically significant (p < 0.01), the value differences in direct bilirubin (DBIL), low‐density lipoprotein cholesterol (LDL‐Ch), and nitrogen (urea) were statistically significant among different severity of COVID‐19 (p < 0.05). Neutrophil/lymphocyte ratio (NLR) had higher sensitivity and specificity for COVID‐19 diagnosis. CONCLUSIONS: Some indices of peripheral blood cell count and general biochemical analysis were valuable in discriminating COVID‐19 and predicting severity and adverse outcome of patients with COVID‐19. For clinician, it is better to use more economical and easy‐to‐get indices to diagnose and predict the prognosis of COVID‐19.

The pandemic of COVID-19 is caused by SARS-CoV-2, 1 as of May 31, 2020, the COVID-19 has spread out all over the World, and over 6.0 million confirmed cases and more than 370,000 deaths were reported globally. 2 According to the published Diagnosis and Treatment Program of 2019 New Coronavirus Pneumonia (seventh trial version), COVID-19 patients are divided into four groups (mild, moderate, severe, and critical), 3 and the COVID-19 patients mainly died from respiratory failure, septic shock, and multiple organ dysfunction syndrome (MODS). [1] [2] [3] [4] Many parameters had used to auxiliary diagnosis and monitoring treatment of COVID-19. IL-6 and IL-10, acted as pro-inflammatory cytokines, 5 can be used as predictors for fast diagnosis of patients with higher risk of disease deterioration and help physicians correctly allocate patients at an early stage. 6 Some urine biochemical parameters are helpful to differentiate COVID-19 patients, and urine glucose and proteinuria can be used as effective markers to predict COVID-19 severity. 7 CRP, as a non-specific marker of inflammation, can reflect the severity of COVID-19 pneumonia in the early stage, and the level of plasma is useful for physicians to stratify patients for intense care unit transfer. 8, 9 According to retrospective cohort study, higher lactate dehydrogenase (LDH) is associated with higher mortality of COVID-19 patients, 10 and 36% patients with COVID-19 had elevated D-dimer. 11 For peripheral blood analysis, severe COVID-19 patients tend to have lower LYM, 12, 13 and the significant reduction in T-lymphocyte subsets was positively correlated with in-hospital mortality and severity following SARS-CoV-2 infection. 14 NLR, as an inflammatory marker, may indicate the condition of glucose metabolism and diabetic control level in type 2 diabetic subjects. 15 Elevated NLR is useful to auxiliary differentiate malign from benign thyroid nodules. 16 NLR was elevated in active ulcerative colitis and may be used as an activity parameter for ulcerative colitis. 17 Except for these parameters, many other parameters also can be easy to get from routine blood and biochemical analysis; meanwhile, numerous patients with COVID-19 were asymptomatic and severe SARS-CoV-2 infection. 18 In order to detect whether other indices from general laboratory testing have prognostic value in patients with COVID-19, and provide more evidence for clinical diagnosis and treatment, we investigated indices of peripheral blood analysis and biochemical analysis in COVID-19 patients.

This study was approved by the institutional ethics board of Renmin Hospital of Wuhan University (No. WDRY2020-K066), and participants signed informed consent forms. were selected as control group. There was no significant difference in terms of sex or age among the four groups (p > 0.05). The detailed criteria are listed as follows:

Moderate group: fever, respiratory tract symptoms, and pneumonia on imaging.

Severe group: Patients have any of the following conditions: respiratory distress, RR ≥ 30 times/minute; the oxygen saturation (SpO 2 ) ≤93% at rest; oxygen partial pressure (PaO 2 )/oxygen concentration (FiO 2 ) in arterial blood ≤ 300 mmHg; and >50% lung imaging progress in the short term within 24-48 h.

Critical group: Patients have any of the following conditions: respiratory failure and mechanical ventilation required; shock; combining other organ failure, intensive care unit is needed.

Approximately 5∼10 ml of peripheral blood was obtained with collection tube from the subjects in each group, serum samples were separated for serum general tests using ADVIA 2400 automatic biochemical analyzer (Siemens Healthcare, Germany) and matching kits, and the blood routine was tested by Sysmex XN900 multifunctional automatic blood cell analyzer (Sysmex Corporation, Kobe, Japan) and matching kits. All data were derived from the first test results upon admission. adverse outcome of patients with COVID-19. For clinician, it is better to use more economical and easy-to-get indices to diagnose and predict the prognosis of COVID-19.

biochemical analysis, COVID-19, peripheral blood cell count, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) SPSS 22 .0 statistical software was used for statistical analysis. Count data were analyzed by the chi-square test; distributed measurement data were expressed as the mean ± SD and were analyzed by t test between two samples normally; and non-normally distributed data are presented as medians with interquartile range (P25, P75) and were analyzed by the nonparametric Mann-Whitney U test or the Wilcoxon signed-rank test. A p value < 0.05 indicates statistical significance.

Except for lymphocyte, in order to detect whether the other re- (Table 1) .

To further examine whether more general biochemical results are associated with COVID-19, we compared general biochemical results from COVID-19 patients and healthy controls ( Table 2 ). The differences in biochemical results, including albumin (ALB), alanine aminotransferase (ALT), aspartate aminotransferase (AST), DBIL, glutamyl transferase (GGT), glucose (Glu), high-density lipoprotein cholesterol (HDL-Ch), LDL-Ch, total bilirubin (TBIL), total cholesterol (TCh), total protein (TP), and uric acid (UA), were statistically significant (p < 0.01) between patients with COVID-19 and healthy controls; however, the differences in alkaline phosphatase (ALP), creatinine (Cr), and triglyceride (TG) between patients with COVID-19 and healthy controls were not statistically significant (p > 0.05).

Lymphocyte count, one result of peripheral blood cell count, was associated with the severity of COVID-19. 13,14 Next, we analyzed the associations of other peripheral blood cell count results with COVID-19 severity (Table 3) . Among different severity of COVID-19, the differences in LYM, Neu, PLT, and WBC were statistically significant (p < 0.05), while the differences in HCT, Hb, MCH, MCHC, MCV, and RBC were not statistically significant (p > 0.05). After multiple comparisons, the results showed that the value of LYM and Neu in moderate cases had significant difference to severe and critical cases (p < 0.05), and the value of LYM, Neu, and WBC in severe cases had no significant difference to critical cases (p > 0.05). The difference in PLT was statistically significant (p = 0.040) between moderate and critical cases. Compared with moderate cases, the difference of WBC in severe cases was statistically significant (p = 0.026), and other results were not statistically significant between different severity (p > 0.05).

Besides D-dimer, CRP, and LDH, to further examine whether more general biochemical results are associated with COVID-19 severity, we compared general biochemical results from different severity of COVID-19 (Table 4 ). Among different severity of COVID-19, the differences in DBIL, LDL-Ch, and urea were statistically significant (p < 0.05), while the differences in ALB, ALP, ALT, AST, Cr, GGT, Glu, HDL-Ch, TBIL, TCh, TG, TP, and UA were not statistically significant 

To evaluate the diagnostic value of LYM, Neu, and NLR in pa- 

Our results suggested that some indices of peripheral blood cell analysis and general biochemical tests performed well in discriminating severity and predicting adverse outcome of COVID-19 patients. It is necessary to use more economical and easy-to-obtain indices of peripheral blood cell count and general biochemical analysis for clinician to diagnose and predict the prognosis of COVID-19;

meanwhile, other indices with diagnostic and predictive value also should be applied as much as possible. According to the prevention and treatment guidelines of the Chinese health department, critical COVID-19 patients were mainly treated in three hospitals of Wuhan during pandemic, so the small number of cases used is a limitation of this study.

We would like to acknowledge the research assistance received and help from Dr Zhu CL (Department of Clinical Laboratory, Renmin

Hospital of Wuhan University, Wuhan 430060, Hubei, China).

We declare that we have no conflicts of interest.

Hospital of Wuhan University (No. WDRY2020-K066), and participants signed informed consent forms.

All datasets are available from the corresponding author upon request.

Qingfeng Ma https://orcid.org/0000-0002-1676-3235

A novel Coronavirus from patients with pneumonia in China

Coronavirus disease (COVID-2019) situation reports

General Office of the National Health Committee of China, China Traditional Chinese Medicine Administration Office. Diagnosis and treatment plan of novel coronavirus pneumonia (seventh trial edition)

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

The pro-and anti-inflammatory properties of the cytokine interleukin-6

Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors

The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019

C-reactive protein levels in the early stage of COVID-19

Plasma CRP level is positively associated with the severity of COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Correlation between relative nasopharyngeal virus RNA load and lymphocyte count disease severity in patients with COVID-19. Viral immunol

Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan

U R E 1 ROC curve for diagnosis of patients with COVID-19

Univariate logistic regression analysis was used to identify COVID-19 patients. Performance of ROC curves of LYM, Neu, and NLR for auxiliary diagnosis of patients with

Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus

Neutrophil to lymphocyte ratio is useful in differentiation of malign and benign thyroid nodules

Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?

Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England

World Health Organization, WHO Director-General's remarks at the media briefing

Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories

Performance du frottis nasopharyngé-PCR pour le diagnostic du Covid-19 -Recommandations pratiques sur la base des premières données scientifiques

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis

The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

China medical treatment expert group for Covid-19, clinical characteristics of coronavirus disease 2019 in China

Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State

Covid-19 in critically Ill patients in the Seattle region-case series

Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation

Acute myocardial injury is common in patients with covid-19 and impairs their prognosis

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China

Laboratory parameters in detection of COVID-19 patients with positive RT-PCR: a diagnostic accuracy study

Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China

Inflammation triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: molecular mechanisms and implications